Shattuck Labs Inc — Quarterly Cash Flow (NASDAQ:STTK) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 111.72 M91.05 M77.17 M64.37 M100.33 M Total liabilities 15.14 M11.42 M9.58 M7.35 M7.09 M Total equity 96.58 M79.63 M67.59 M57.02 M93.24 M Total liabilities & shareholders' equities 111.72 M91.05 M77.17 M64.37 M100.33 M Total debt ————— Net debt —————

뉴스

샤툭 랩스(STTK), Piper Sandler ’비중확대’ 의견 제시

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

샤툭 랩스(STTK), H.C. Wainwright 투자의견 ’매수’로 상향

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

Shattuck Labs, 혁신적인 IBD 치료법 제시

Shattuck Labs at UEG Congress: Innovative IBD Treatment Insights

What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?

Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?